Meanwhile, Tan also expects ThaiBev’s spirits segment to continue its strong performance moving into 2HFY2023, as anticipated government handouts from a newly-elected government would spur consumption.
UOB Kay Hian analysts have added Raffles Medical (SGX:BSL
) and Thai Beverage (ThaiBev) (SGX:Y92) to its alpha picks portfolio amid favourable tailwinds and upcoming near-term catalysts.
Raffles Medical is set to benefit from the Transitional Care Facilities (TCF) inclusion into Singapore’s healthcare ecosystem. With healthy margins due to its asset-light nature, contributing nearly 40% of the company’s operating profit, the TCF will help support Raffles Medical’s profit for 2023 and 2024, analyst Llelleythan Tan point out.
